Royal Bank of Canada (LON:0QKU)

Sage Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is November - October.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020
Market Capitalization	136,963	132,790	92,146	111,903	108,159	76,876
Market Cap Growth	15.96%	44.11%	-17.66%	3.46%	40.69%	-14.14%
Last Close Price	96.89	92.08	61.75	72.24	66.42	42.63
PE Ratio	14.18	14.97	10.80	11.28	11.63	11.87
PS Ratio	4.34	4.40	3.17	3.62	3.64	3.09
PB Ratio	1.90	1.87	1.35	1.62	1.86	1.53
P/FCF Ratio	-	-	-	-	-	14.15
P/OCF Ratio	-	-	-	-	-	11.05
Debt / Equity Ratio	3.69	3.94	4.43	4.27	3.81	4.70
Debt / FCF Ratio	-	-	-	-	-	43.54
Return on Equity (ROE)	14.35%	13.40%	13.09%	15.28%	17.30%	13.42%
Return on Assets (ROA)	0.85%	0.78%	0.74%	0.87%	0.96%	0.75%
Earnings Yield	7.05%	6.81%	9.41%	9.00%	8.74%	8.63%
FCF Yield	-15.98%	-29.70%	-13.30%	-50.79%	-16.36%	7.07%
Dividend Yield	2.55%	3.39%	5.13%	4.38%	3.83%	5.84%
Payout Ratio	46.36%	40.89%	37.99%	44.07%	40.03%	55.40%
Buyback Yield / Dilution	-0.82%	-1.52%	0.96%	1.45%	0.14%	0.83%
Total Shareholder Return	1.72%	1.87%	6.09%	5.83%	3.98%	6.66%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.